Cargando…
Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer
BACKGROUND: Non-small cell lung cancer (NSCLC) is the main type of lung cancer and NSCLC patients always have a low 5-year survival rate. It is vital to identify a biomarker for the prognosis of NSCLC patients. AT-rich interaction domain 1a (ARID1A) is a tumor suppressor that is involved in the prog...
Autores principales: | Wang, Tao, Guo, Jinyan, Liu, Wenhua, Guo, Qi, Cheng, Lvhuan, Zheng, Renshan, Hu, Xinchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798606/ https://www.ncbi.nlm.nih.gov/pubmed/35117851 http://dx.doi.org/10.21037/tcr-20-2263 |
Ejemplares similares
-
VEGI downregulation is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma
por: Xu, Yinhai, et al.
Publicado: (2021) -
Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2021) -
Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
por: Li, Yong, et al.
Publicado: (2020) -
Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
por: Zhu, Bojin, et al.
Publicado: (2018) -
Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients
por: Zhao, Cong, et al.
Publicado: (2022)